Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin T. Conroy currently holds 1,101,519 shares of Epizyme, Inc. (EPZM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin T. Conroy has been a net seller of EPZM stock. They have purchased $426.4K and sold $176.8M worth of shares.
Kevin T. Conroy's most recent insider trade was on Dec 23, 2025, when they sold 244,931 shares at $0.00 per share.
Kevin T. Conroy serves as Executive at Epizyme, Inc. (EPZM). They have executed 291 insider transactions totaling $177.3M over their tenure at the company.
Kevin T. Conroy holds the position of Executive at Epizyme, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kevin T. Conroy has shown a selling trading pattern, with $426.4K in total purchases and $176.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin T. Conroy was on Dec 23, 2025, when they sold $15.8M worth of EXAS shares. This transaction involved 155,417 shares at $101.82 per share.
Kevin T. Conroy currently owns 1,101,519 shares of Epizyme, Inc. (EPZM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin T. Conroy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin T. Conroy has 291 Form 4 filings on record as an insider at Epizyme, Inc..
Set alerts for Kevin T. Conroy and 40,000+ other insiders.